SUMMARY The clinical and laboratory details of 10 patients with predominantly immunological problems were circulated to selected physicians in different forms of hospital practice. In general, these physicians would prefer to select their own immunological tasks and could get these performed in their clinical pathology laboratories or regional immunology centres. Immunologists are seen predominantly as laboratory-based advisers rather than clinicians responsible for the care of such patients.
Immunology pervades the activities of most clinicians. This is scarcely surprising since so much human disease results from the failure to combat infectious agents or from allergic reactions to antigens in the form of drugs, chemicals, or simple flora and fauna. The importance of immunological mechanisms in the pathogenesis of disease is reflected in the context of prophylactic immunisation or the therapeutic manipulation of the immune response. These intellectual and practical considerations have provided the stimulus for establishing the new discipline of clinical immunology.
Traditionally clinical specialties have been organised according to the dictates of medical practice and, in general, physicians are classified according to their practical skills. Thus doctors with a penchant for investigating gastrointestinal complaints became recognised as gastroenterologists by their colleagues and learned to manipulate the instruments which transformed this specialty from one based on opinion to one based upon exact observation. Similarly, with the growth of medical science, diagnostic services were provided by laboratories with experience in the various branches of clinical pathology. Thus a logical system was devised whereby the patient's symptoms provide the first sign-post to the relevant clinical specialist and thereafter essential specimens are sent to the appropriate laboratory.
Advances in clinical sciences have complicated the operation of so simple a system. For example haematologists command a wide knowledge of clinical and laboratory practice. It is widely accepted therefore that haematologists must have access to both beds and laboratory facilities so as to provide the best possible service for their patients. The dilemma facing immunologists is apparently similar to that of haematologists and they must find the best way in which increasing knowledge of immunological mechanisms in disease can be applied to the investigation and management of clinical problems. It is necessary, however, to make a firm distinction between academic immunology and immunology in clinical practice. The way in which T lymphocytes recognise antigens is a fundamental problem whose solution will have enormous therapeutic implications. This does not imply that a scientist investigating this problem should be integrated into institutions or teams dealing with clinical medicine. There may be circumstances in which the scientist investigating such fundamental problems is not only clinically qualified but also uses clinical material as the basis for much of his thinking and experimental work. This is not necessarily so and the situation is likely to arise only in academic centres.
There are two principal ways in which immunology affects clinical practice. The first arises when clinicians ask for immunological tests to manage a particular patient. Some In 1974, at the age of 46, hypogammaglobulinaemia was first suspected and diagnosed. Regular treatment with gamma globulin injections and steroids was started but the latter were discontinued after two years. There is no family history of immunodeficiency.
Her current admission was precipitated by 6 months' cough and sputum, watery diarrhoea, and increasing tiredness. She was receiving no medication apart from y-globulin injections.
On examination there were scattered small bruises on the legs; coarse crepitations were heard at both lung bases. Investigations revealed an Hb of 8-3 g/dl falling to 6-8 g/dl over 2 weeks observation with a macrocytosis of 120 fi and a reticulocyte count of 21-5%. The CASE 7 is a 21-year-old woman who developed tenosynovitis 18 months ago. The arthritis spread over the next 12 months and has been progressively disabling.
In the past 6 months she has suffered sore throats, recurrent mouth ulcers, intermittent fever, and worsening lethargy. She has also noted recurrent pleuritic pain and dyspnoea on exertion. She has lost 10 kg weight in the past 2 months. She has received various non-steroidal anti-inflammatory drugs, short courses of gold, and penicillamine.
She was pale, underweight, and febrile (390C) with generalised firm lymphadenopathy. There was minimal symmetrical soft tissue swelling of small joints in the hands and feet.
There was no rash or vasculitic lesions. Systemic examination was normal save that fine inspiratory crackles were heard at both lung bases.
Investigations revealed a normochromic, normocytic anaemia, Hb 8-2 g/dl, WBC 4 5 x 109/l, with granulocytes 2621/1l and lymphocytes 1428/pJ, platelets 295 x 109/l and ESR 131 mm. The blood urea was 8-1 mmol/l, electrolytes normal, albumin 25 g/l, total globulin 38 g/l, and serum iron 6 /Imol/l.
No other biochemical abnormalities were noted. Renal disease was indicated by 10 x 106 leucocytes and 160 x 106 RBC/1 urine, 5*1 g proteinuria/24 h and a reduced GFR 55 ml/min. Creatinine clearance was normal and the urine was sterile. The direct Coombs test was negative. The serum IgG concentration was raised at 21 1 g/l but other immunoglobulin concentrations were normal. Total haemolytic complement was reduced at 1 in 2, as was the C 3, 24 mg/100 ml and C 4, 4 mg/100 ml. Antinuclear antibody was detected at a titre of 1/1280; precipitating antibodies to DNA and ENA and C 1q binding material were readily detectable.
The chest x-ray showed minor left lower lobe consolidation, and lung function tests showed severely impaired lung capacity, flow rate, and gas exchange.
Questions
We would all accept that this girl is suffering from systemic lupus erythematosus.
( All abnormalities were confined to the central nervous system. There was no intellectual deterioration and the cranial nerves were intact. There was symmetrical weakness and wasting of the muscles in both the upper and lower limbs, more marked distally. There was sensory impairment affecting all modalities in the same distribution as the motor changes. The clinical diagnosis was a chronic demyelinating polyneuropathy. Investigations showed Hb 16-2 g/dl with normal red cell indices, WBC 9 x 109/l, with a normal differential, ESR 27 mm and total serum globulin 33 g/l, IgG 7-4 g/l, IgA 1-9 g/l, IgM 7-2 g/l.
Other biochemical tests, serum B12 and folate concentrations were normal. The WR and VDRL were negative in the blood and CSF; no excessive porphyrinuria was detected. Bone x-rays and scans were normal, and a computerised body scan showed no evidence of a neoplasm. The only CSF abnormality was an increase of protein (Il75 g/l No immunological abnormalities were found in the blood. The renal biopsy showed immune complex deposits in the glomeruli by immunofluorescence and electron-microscopy. Three months later the first radiological evidence appeared of carcinoma of the bronchus and this diagnosis has been confirmed histologically.
Case 9: Cardiopulmonary disease Circulating immune complexes, rheumatoid factor and precipitating serum antibodies to extractable nuclear antigens were detected in high titre and these changes were associated with a marked reduction in circulating T lymphocytes. These abnormalities are consistent with systemic sclerosis but we do not consider them diagnostic.
Case 10: Polyneuropathy The patient has a kappa paraprotein which is weakly auto-reactive with myelin. He is being treated with plasniaphoresis and cytotoxic drugs but so far without apparent benefit. 
